Current evidence on the safety profile of NSAIDs for the treatment of PDA

Costantino Romagnoli, Iliana Bersani, Serena Antonia Rubortone, Serafina Lacerenza, Maria Pia De Carolis

Research output: Contribution to journalArticlepeer-review


Patent ductus arteriosus (PDA) complicates the clinical course of preterm infants. Nonsteroidal anti-inflammatory drugs, especially Indomethacin and Ibuprofen, have been widely used for both prevention and treatment of PDA. Short-term efficacy of Indomethacin or Ibuprofen is equivalent, while Ibuprofen results show a higher safety profile. Ibuprofen is associated with fewer clinical gastrointestinal and renal side effects with respect to Indomethacin even if subclinical potential effects are reported. When administered as prophylaxis, Ibuprofen has no effects on prevention of intraventricular haemorrhage unlike Indomethacin. Considering the potential adverse effects of both these drugs, a careful monitoring during and after the treatment period is highly recommended.

Original languageEnglish
Pages (from-to)10-13
Number of pages4
JournalJournal of Maternal-Fetal and Neonatal Medicine
Issue numberSUPPL. 3
Publication statusPublished - Nov 2011


  • ibuprofen
  • indomethacin
  • neonate
  • non steroidal anti-inflammatory drugs
  • Patent ductus arteriosus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology


Dive into the research topics of 'Current evidence on the safety profile of NSAIDs for the treatment of PDA'. Together they form a unique fingerprint.

Cite this